ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01474577
Recruitment Status : Completed
First Posted : November 18, 2011
Last Update Posted : April 9, 2018
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?

Condition or disease Intervention/treatment
Cardiac Health Other: questionnaire

Study Type : Observational
Actual Enrollment : 57 participants
Observational Model: Cohort
Time Perspective: Retrospective
Actual Study Start Date : November 8, 2011
Actual Primary Completion Date : May 18, 2017
Actual Study Completion Date : May 18, 2017

Group/Cohort Intervention/treatment
pts who have had Rb-82 PET myocardial perfusion imaging
Eligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone.
Other: questionnaire
Patients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record.




Primary Outcome Measures :
  1. correlate scan findings with clinical outcomes [ Time Frame: 1 year ]
    Patients will complete one questionnaire over the phone.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008—2011.
Criteria

Inclusion Criteria:

  • Patient > or = to 18 years of age
  • Registered patient at MSKCC
  • Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008—2011

Exclusion Criteria:

  • Patient is unwilling to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01474577


Locations
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Principal Investigator: Heiko Schöder, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01474577     History of Changes
Other Study ID Numbers: 11-150
First Posted: November 18, 2011    Key Record Dates
Last Update Posted: April 9, 2018
Last Verified: November 2016

Keywords provided by Memorial Sloan Kettering Cancer Center:
stress test
cardiac issues
Rb-82 PET Myocardial Perfusion Imaging
11-150
one or more 82Rb myocardial perfusion stress tests